期刊文献+

还原型谷胱甘肽对恶性肿瘤化疗后肝损伤的疗效观察 被引量:13

Therapeutic Function of Reduced Glutathione to Liver Injury after Chemo-therapy of Cancer
下载PDF
导出
摘要 [目的]观察还原型谷胱甘肽(glutathione,GSH)对化疗药物性肝功能损害的防治作用。[方法]将56例恶性肿瘤患者随机分为观察组及对照组,观察组化疗时联合使用GSH,对照组化疗时联合使用复方甘草酸铵,分别对两组患者治疗后肝功能情况进行观察和比较。[结果]观察组肝功能损伤率低于对照组(P<0.05)。[结论]GSH对恶性肿瘤化疗药物性肝功能损害具有较好的防治作用。 [Objective] To observe the prevention of reduced glutathione(GSH) to chemotherapeutics liver injury.[Method] Randomly divide 56 cases into observation and control groups; the observation group used GSH in chemotherapy,while the control one,compound ammonium glycyrrhetate;respectively observe and compare the liver functions after treatment.[Result] In observation group,the liver injury rate was less than that in control one.[Conclusion] GSH has good prevention to cancer chemotherapeutics liver injury.
作者 张剑
出处 《浙江中医药大学学报》 CAS 2014年第5期601-602,共2页 Journal of Zhejiang Chinese Medical University
关键词 药物性肝功能损害 化疗药物 恶性肿瘤 GSH chemotherapeutic liver injury chemo-therapy drugs malignant tumor GSH
  • 相关文献

参考文献5

二级参考文献12

共引文献53

同被引文献110

  • 1崔宪珍,刘都户.还原型谷胱甘肽防治化疗药物肝损害126例临床观察[J].陕西医学杂志,2008,37(7):931-932. 被引量:16
  • 2Romaric Loffroy,Louis Estivalet,Violaine Cherblanc,Sylvain Favelier,Pierre Pottecher,Samia Hamza,Anne Minello,Patrick Hillon,Pierre Thouant,Pierre-Henri Lefevre,Denis Krausé,Jean-Pierre Cercueil.Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage[J].World Journal of Gastroenterology,2013,19(37):6131-6143. 被引量:25
  • 3张雪芳,成彩琴,杨丽.肿瘤免疫治疗机在临床中对肿瘤化疗患者的应用分析[J].中外健康文摘,2014,(03): 120-120.
  • 4LeonardiDS,deCMB,FeresGV,etal.Low-carbohydrateandhigh-fatdietsonthepromotionofhepaticsteatosisinrats[J].Experimentalandclinicalendocrinology&diabetes,2010,118(10):221-223.
  • 5PacanaT,SanyalAJ.VitaminEandnonalcoholicfattyliverdisease[J].Currentopinioninclinicalnutritionandmetaboliccare,2012,15(6):112-114.
  • 6Pakin DM, Bray F, Ferlay J, et al. Estimating the world cancerburden:Globocan2000. IntJ Cancer, 2011, 94: 153-156.
  • 7KREJS G J. Gastric cancer: epidemiology and risk factors[J]. Digestive Diseases, 2010,28(4/5) : 600-603.
  • 8CUNNINGHAM D, STARLING N, RAO S, et al. Capeci tabine and oxaliplatin for advanced esophagogastric cancer[J]. N Engl J Med, 2008,358(1):36-46.
  • 9MONTAGNANI F, TURRISI G, MARINOZZI C, et al. Ef- fectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis[J]. Gastric Cancer, 2011,14(1) :50-55.
  • 10陈建清,胡良凯,张建民.熊去氧胆酸在胆汁淤积性肝病中的应用[J].国际消化病杂志,2008,28(6):474-476. 被引量:14

引证文献13

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部